1. Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010; 5:17. PMID:
20537182.
Article
2. Chelimsky G, Davis ID, Kliegman RM. Neonatal hyponatremia associated with congenital hypothyroidism. Clin Pediatr (Phila). 1997; 36:177–180. PMID:
9078421.
Article
3. Schutt-Aine JC. Hypothyroid myxedema and hyponatremia in an eight-year-old child: a case report. J Natl Med Assoc. 1980; 72:705–708. PMID:
7392090.
4. Agathis NT, Libman IM, Moritz ML. Hyponatremia due to severe primary hypothyroidism in an infant. Front Pediatr. 2015; 3:96. PMID:
26618147.
Article
5. Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet. 1997; 350:755–756. PMID:
9297992.
Article
6. Ota K, Kimura T, Sakurada T, Shoji M, Inoue M, Sato K, et al. Effects of an acute water load on plasma ANP and AVP, and renal water handling in hypothyroidism: comparison of before and after L-thyroxine treatment. Endocr J. 1994; 41:99–105. PMID:
7951559.
Article
7. Brown RS, Demmer LA. The etiology of thyroid dysgenesis-still an enigma after all these years. J Clin Endocrinol Metab. 2002; 87:4069–4071. PMID:
12213847.
Article
8. Korkmaz L, AkıZn MA, Güneş T, Daar G, Baştuğ O, Yıkılmaz A, et al. Unusual course of congenital hypothyroidism and route of the L-thyroxine treatment in a preterm newborn. J Clin Res Pediatr Endocrinol. 2014; 6:177–179. PMID:
25241613.
Article
9. Seth A, Aggarwal V, Maheshwari A. Hypothyroidism in children beyond 5 y of age: delayed diagnosis of congenital hypothyroidism. Indian J Pediatr. 2012; 79:891–895. PMID:
22237638.
Article
10. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med. 1978; 64:613–621. PMID:
645727.
Article
11. Kimura T. Potential mechanisms of hypothyroidism-induced hyponatremia. Intern Med. 2000; 39:1002–1003. PMID:
11197779.
Article
12. Laczi F, Janáky T, Iványi T, Julesz J, László FA. Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease. Acta Endocrinol (Copenh). 1987; 114:389–395. PMID:
3564840.
Article
13. Iwasaki Y, Oiso Y, Yamauchi K, Takatsuki K, Kondo K, Hasegawa H, et al. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab. 1990; 70:534–539. PMID:
2298864.
Article
14. Koide Y, Oda K, Shimizu K, Shimizu A, Nabeshima I, Kimura S, et al. Hyponatremia without inappropriate secretion of vasopressin in a case of myxedema coma. Endocrinol Jpn. 1982; 29:363–368. PMID:
7173113.
Article
15. Park CW, Shin YS, Ahn SJ, Kim SY, Choi EJ, Chang YS, et al. Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema. Nephrol Dial Transplant. 2001; 16:1799–1806. PMID:
11522861.
Article
16. Munro DS, Renschler H, Wilson GM. Exchangeable potassium and sodium in hyperthyroidism and hypothyroidism. Metabolism. 1958; 7:124–132. PMID:
13516463.
17. Villabona C, Sahun M, Roca M, Mora J, Gómez N, Gómez JM, et al. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci. 1999; 318:277–280. PMID:
10522555.
Article
18. Nakhoul F, Thompson CB, McDonough AA. Developmental change in Na, K-ATPase alpha1 and beta1 expression in normal and hypothyroid rat renal cortex. Am J Nephrol. 2000; 20:225–231. PMID:
10878407.
Article
19. Kohno M, Takaori K, Matsuura T, Murakawa K, Kanayama Y, Takeda T. Atrial natriuretic polypeptide in atria and plasma in experimental hyperthyroidism and hypothyroidism. Biochem Biophys Res Commun. 1986; 134:178–183. PMID:
2936340.
Article
20. Ruiz M, Montiel M, Jimenez E, Morell M. Effect of thyroid hormones on angiotensinogen production in the rat in vivo and in vitro. J Endocrinol. 1987; 115:311–315. PMID:
3325607.
Article